Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis faetor-α antibody therapy

Clinical and Experimental Rheumatology

Volumn 26, Issue 2, 2008, Pages 261-267

  Sekigawa, Iwao ^a,b   Yanagida, Mitsuaki ^b   Iwabuchi, Kazuhisa ^b   Kaneda, Kazuhiko ^a   Kaneko, Hiroshi ^a   Takasaki, Yoshinari ^c   Jung, Giman ^d   Sone, Saburo ^d   Tanaka, Yoshinari ^d   Ogawa, Hideoki ^b   Takamori, Kenji ^a,b  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TORAY INDUSTRIES INC   (Japan)

Author keywords

Anti TNF antibody; Connective tissue growth factor (CTGF); Mass spectrometry; Proteomics; Rheumatoid arthritis

Indexed keywords

ACTARIT; AMYLASE; BIOCHEMICAL MARKER; BUCILLAMINE; CALDESMON; CALDESMON 1 ISOFORM 1; CONNECTIVE TISSUE GROWTH FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FILAMIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; ISOMERASE; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; METHOTREXATE; MIZORIBINE; MYOGLOBIN; NCK PROTEIN; PEPTIDYLPROLYL ISOMERASE A ISOFORM 1; PEPTIDYLPROLYL ISOMERASE B PRECURSOR; PLASMA PROTEIN; PREDNISOLONE; PROTEOHEPARAN SULFATE; SALAZOSULFAPYRIDINE; TRANSGELIN; TRANSGELIN 2; TROPOMODULIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; ARTICULAR CARTILAGE; BONE REGENERATION; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE; TWO DIMENSIONAL LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43349093924     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MAINI P, WILLIAM ST CLAIR E, BREEDVELD F et al.: Infliximab (chimeric anti-tumor necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. Lancet 1999; 54: 1932-9.
2. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996; 14: 397-440.
3. FASSBENDER HG, SEIBEL M, HEBERT T: Pathways of destruction in metacarpal and metatarsal joints of patients with rheumatoid arthritis. Scand J Rheumatol 1992; 21: 10-6.
4. FELDMANN M, MAINI RN: Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163-96.
5. KLIMIUK PA, SIERAKOWSKI S, DOMYSLAWSKA I, CHWIECKO J: Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: 529-33.
6. MAINI RN, ELLIOTT MJ, FM BRENNAN et al.: Monoclonal anti-TNFα antibodies as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995; 144: 195-223.
7. REDLICH K, HAYER S, RICCI R et al.: Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 2002; 110: 1419-27.
8. ANDERSON NL, ANDERSONHNG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-67.
9. TANAKA Y, AKIYAMA H, KURODA T et al.: A novel approach and protocol for discovering extremely low-abundance proteins in serum. Proteomics 2006; 6: 4845-55.
10. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998; 31: 315-24.
11. STEINBROCKER O, TRAEGER CH, BATTERMAN RC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
12. PREVOO ML, VAN'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB, VAN RIEL PL: Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
13. FELSON DT, ANDERSON JJ, BOERS M et al.: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
14. TIRUMALAI RS, CHAN KC, PRIETO DA, ISSAQ HJ, CONRADS TP, VEENSTRA TD: Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2003; 2: 1096-103.
15. WASHBURN MP, ULASZEK RR, YATES JR 3rd: Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem 2003; 75: 5054-61.
16. LIU H, SADYGOV RG, YATES JR 3rd: A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004; 76: 4193-201.
17. ISHIHAMA Y, ODA Y, TABATA T et al.: Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005; 4: 1265-72.
18. BERNTZEN HB, MUNTHE E, FAGERHOL MK: The major leukocyte protein L1 as an indicator of inflammatory joint disease. Scand J Rheumatol 1998; 76 (Suppl.): 251-6.
19. KERKHOFF C, KLEMPT M, SORG C: Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochimica et Biophysica Acta 1998; 1448: 200-11.
20. DRYNDA S, RINGEL B, KEKOW M et al.: Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract 2004; 200: 165-71.
21. MORRIS NJ, ROSS SA, NEVEU JM, LANE WS, LIENHARD GE: Cloning and preliminary characterization of a 121 kDa protein with multiple predicted C2 domains. Biochimica et Biophysica Acta 1999; 1431: 525-30.
22. BOUWMEESTER T, BAUCH A, RUFFNER H et al.: A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004; 6: 97-105.
23. JIMI E, GHOSH S: Role of nuclear factor-kappaB in the immune system and bone. Immunol Rev 2005; 208: 80-7.
24. HAN Z, BOYLE DL, MANNING AM, FIRESTEIN GS: AP-1 and NF-KB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 1998; 28: 197-208.
25. WEINBLATT ME, KREMER JM, BANKHUST AD et al.: A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253-9.
26. BRIGSTOCK AR: The CCN family: a new stimulus package. J Endcrinol 2003; 178: 169-75.
27. NAKAO K, KUBOTA S, DOI H et al.: Collaborative action of M-CSF and CTGF/CC2 in aricular chondrocytes: Possible regenerative roles in articular cartilage metabolism. Bone 2005; 36: 884-92.
28. ABRAHAM DJ, SHIWEN X, BLACK CM, SA S, XU Y, LEASE A: Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 2000; 19: 15220-5.
29. HATTORI T, KAWAKI H, KUBOTA S et al.: Downregulation of a rheumatoid arthritis-related antigen (RA-A47) by ra-a47 antisense oligonucleotides induces inflammatory factors in chondrocytes. J Cell Physiol 2003; 197: 94-102.
30. SAKAMOTO N, SUGIMURA K, KAWASHIMA H et al.: Influence of glucose and inflammatory cytokines on TGF-beta 1 and CTGF mRNA expressions in human peritoneal mesothelial cells. Int J Mol Med 2005; 15: 907-11.
31. BEDDY D, MULSOW J, WATSON RW, FITZ-PATRICK JM, O'CONNELL PR: Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg 2006; 93: 1290-6.
32. LIAO H, WU J, KUHN E et al.: Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004; 50: 3792-803.
33. ALI M, MANOLIOS N: ProAeomics in rheumatology: a new direction for old diseases. Semin Arthritis Rheum 2005; 35: 67-76.